Two fears, one decision

Two fears sit at the centre of most delayed hip replacement decisions, and they pull in opposite directions. The first is acting too soon: accepting surgery before it is truly necessary, only to outlive the implant and face revision in later life. The second is waiting too long: allowing the joint to deteriorate to the point where the body that must recover from surgery is weaker, the bone less sound, and the procedure itself more demanding than it needed to be. Neither fear is irrational — both reflect something real about how hip replacement works and how the hip joint responds to prolonged disease. What has changed is the weight of evidence on each side. The longevity of modern implants and the documented harms of late presentation have both shifted meaningfully in recent years, and for many patients still hesitating, the balance between those two risks now looks quite different from the one their surgeon described a decade ago.

How long do modern hip implants actually last?

The figure many patients encounter online — that roughly 58% of hip replacements last 25 years — was generated using bearing surfaces that are no longer in routine use. Metal-on-conventional polyethylene, the dominant pairing when those statistics were compiled, has been largely replaced by highly cross-linked polyethylene and ceramic constructs that wear at a fraction of the earlier rate. The revision figures attached to older materials do not straightforwardly apply to implants placed today.

On current National Joint Registry data, approximately 85% of total hip replacements survive 20 years without needing revision; fixed-bearing implants reach 90.2% survival at the 10-year mark. A February 2026 global study using NJR data confirmed that modern hip replacements can, for the right indication and with appropriate preparation, support more than 30 years of function. That does not mean every implant will reach that benchmark — individual anatomy, activity level, and how precisely the implant is positioned all play a part — but it represents a meaningfully different evidence landscape from the one that shaped the 'wait as long as possible' advice many patients received a decade ago.

Revision risk remains sensitive to age at the time of surgery. Patients under 50 carry an estimated lifetime revision risk of around 35%; that figure falls to approximately 20% for those aged 50–59, around 9% for those in their 60s, and roughly 5% for patients over 70. These gradients still matter and younger patients' concerns are real. The picture is, however, considerably more favourable than the statistics in wide circulation suggest.

What actually happens to the hip while you wait

Osteoarthritis does not pause while a decision is being made. Cartilage loss, bone deterioration, and slow joint deformity continue advancing regardless of whether surgery is on the horizon — and the joint a surgeon eventually operates on may be considerably more damaged than the one that first warranted assessment.

Chronic pain has a predictable effect on behaviour: it enforces rest. The enforced inactivity that follows months or years of uncontrolled hip pain generates significant muscle atrophy around the hip joint. Those weakened muscles are then the ones expected to support rehabilitation after surgery. Clinical evidence suggests that patients presenting late tend to face a longer and harder recovery, not because the operation has gone wrong but because the body surrounding the new joint is deconditioned before it begins.

Limping is a natural protective response, but it carries a cost. Compensating for a painful hip transfers abnormal mechanical load to the knee, the lower back, and the opposite leg. The longer that gait pattern persists, the greater the risk of secondary joint deterioration in those areas — damage that the hip replacement, however successful, cannot undo.

Perhaps less widely understood is the effect of prolonged disuse on bone quality. Long-term hip immobility can lead to localised osteoporosis, which may increase the risk of intraoperative femoral fracture at the time of eventual surgery. Advanced joint deformity can also restrict implant options and raise the technical complexity of the procedure itself. Delay, in other words, does not simply push a straightforward operation into the future — in some cases, it actively changes the nature of that operation.

What conservative treatment can and cannot do

Conservative treatment has a genuine and important place in this journey. Physiotherapy can maintain strength and range of motion; weight management reduces load on a deteriorating joint; anti-inflammatory medication can take the edge off daily pain; and biological options such as hyaluronic acid gel or micro-fragmented fat injections may buy meaningful time for appropriately selected patients. None of this is window dressing — used at the right stage, these measures can make real differences to daily function.

What they cannot do is stop the underlying process. Osteoarthritis continues to progress regardless of how well symptoms are managed. Conservative treatments address the experience of the disease, not its trajectory. The joint continues to change; the question is whether the patient's symptoms and function remain adequately controlled while it does.

That distinction matters because 'still trying conservative options' describes two very different situations. For a patient whose symptoms remain manageable and whose joint structure is not yet critically compromised, continued non-operative management may be entirely appropriate. For a patient whose pain breaks through at night, whose walking distance has collapsed, and whose imaging shows advanced deterioration, the same approach has crossed from prudent deferral into compounding harm.

The signals that mark that crossing — persistent daily pain, disturbed sleep, and meaningful loss of daily function — are the subject of the next section.

Symptoms and signs that make specialist review overdue

Four patterns in particular suggest that hesitation has moved past clinical prudence.

The first is pain that no longer responds to rest. Groin ache, discomfort along the front of the thigh, or a persistent pressure at the outer hip are the characteristic distributions of hip joint disease. When those sensations continue through sitting, lying down, or a night's sleep — and when night pain breaks through despite analgesia — the joint is signalling that its capacity for self-limitation has been exceeded. Pain that disrupts sleep is clinically significant: it indicates a level of structural compromise and inflammation that conservative management is no longer reaching.

The second is functional contraction. When stairs become a deliberate calculation, walking distance shrinks to manage pain rather than reflect fitness, or routine tasks such as putting on shoes demand workarounds, the joint is already narrowing the patient's life in measurable ways.

The third is what imaging confirms rather than implies. X-rays showing marked joint-space narrowing, bone-on-bone contact, or progressive deformity describe a joint whose deterioration is actively accumulating — not static background information.

The fourth is a failed treatment trail. When multiple conservative strategies have been tried in earnest and no longer hold symptoms at a tolerable level, continued non-operative management crosses from caution into compounding the situation.

A specialist review at this point is not a commitment to surgery. Surgeons with deep experience in hip replacement decision-making — Professor Paul Lee among them — typically evaluate patients across four dimensions before any recommendation is formed: the severity of current symptoms, the degree of structural change on imaging, the treatments already exhausted, and the patient's own readiness for a significant procedure. That structured approach exists to ensure that all options have been properly considered. Crucially, it also means that a patient is not advised to keep waiting when waiting itself has become the source of harm.

How surgical technique fits into the timing decision

The timing question cannot be separated from the surgical context in which replacement would take place. An approach that disturbs fewer muscles and preserves the key posterior tendons changes both the risk profile of the operation and the recovery trajectory that follows — which is directly relevant to when a patient chooses to proceed.

Professor Lee's SPAIRE technique — Saves Piriformis And Internus with Repair of Externus — is built around that principle: leaving the major posterior soft tissues intact rather than dividing them during the approach. The clinical consequence is a substantially reduced dislocation risk and earlier confident mobilisation, since the stabilising structures the hip depends on are not waiting to heal from surgical disruption. This is one reason technique and timing are connected: a more tissue-preserving approach is less dependent on the patient arriving in peak musculoskeletal condition. Where significant muscle atrophy has already developed through prolonged delay, rehabilitation is harder regardless of how carefully the operation itself is performed.

A structured biological rapid recovery programme designed around this approach — integrating implant choice, mobilisation planning, and recovery pathway design — means selected patients who proceed within the right functional window may experience a meaningfully different post-operative course. That outcome remains pathway-specific and shaped by individual anatomy, bone stock, and general health; it is not a uniform promise.

The evidence across this article points in a consistent direction. Modern implants outlast the statistics many patients have memorised. Delay accumulates structural and muscular harms that cannot be reversed by eventual surgery. And surgical technique has advanced in ways that reduce the risks historically used as grounds for indefinite waiting. For patients who have been deferring, these three shifts together suggest that the balance has moved — and that establishing clearly where the situation sits is a more useful next step than continued uncertainty.